These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27587544)

  • 1. Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis.
    Sotgiu G; Tiberi S; D'Ambrosio L; Centis R; Alffenaar JW; Caminero JA; Abdo Arbex M; Alarcon Guizado V; Aleksa A; Dore S; Gaga M; Gualano G; Kunst H; Payen MC; Roby Arias AJ; Skrahina A; Solovic I; Sulis G; Tadolini M; Zumla A; Migliori GB;
    Eur Respir J; 2016 Nov; 48(5):1503-1507. PubMed ID: 27587544
    [No Abstract]   [Full Text] [Related]  

  • 2. Is Shorter Treatment Regimen for Multidrug-resistant Tuberculosis feasible in Indian Children?
    Shah I
    Indian Pediatr; 2017 Feb; 54(2):160. PubMed ID: 28285296
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015.
    Dalcolmo M; Gayoso R; Sotgiu G; D'Ambrosio L; Rocha JL; Borga L; Fandinho F; Braga JU; Arakaki Sanchez D; Dockhorn F; Centis R; Migliori GB
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404651
    [No Abstract]   [Full Text] [Related]  

  • 4. Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope.
    Prasad R; Gupta N; Banka A
    Indian J Med Res; 2017 Sep; 146(3):301-303. PubMed ID: 29355135
    [No Abstract]   [Full Text] [Related]  

  • 5. The shorter multidrug-resistant tuberculosis treatment regimen in Singapore: are patients from South-East Asia eligible?
    Chee CBE; KhinMar KW; Sng LH; Jureen R; Cutter J; Lee VJM; Wang YT
    Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28798092
    [No Abstract]   [Full Text] [Related]  

  • 6. [Consideration on the use of injectable anti-tuberculosis drufgs in the treatment of drug-resistant tuberculosis in china].
    Liu YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):401-404. PubMed ID: 31189224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired drug resistance because of pharmacokinetic variability in a young child with tuberculosis.
    Pasipanodya JG; Srivastava S; Gumbo T
    Pediatr Infect Dis J; 2014 Nov; 33(11):1205. PubMed ID: 25361414
    [No Abstract]   [Full Text] [Related]  

  • 8. In reply: Acquired drug-resistance because of pharmacokinetic variability in a young child with tuberculosis.
    Garcia-Prats AJ; Donald PR; Schaaf HS
    Pediatr Infect Dis J; 2014 Nov; 33(11):1205-6. PubMed ID: 25361415
    [No Abstract]   [Full Text] [Related]  

  • 9. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen.
    Achar J; Berry C; Herboczek K; Parpieva N; Tillyashaykhov MN; Tigay ZN; Khamraev A; Velivela K; Seddon JA; du Cros P
    Emerg Infect Dis; 2015 Nov; 21(11):2105-6. PubMed ID: 26488556
    [No Abstract]   [Full Text] [Related]  

  • 10. Linezolid in children with drug resistant tuberculosis.
    Shah I; Dey A; Shetty NS
    Infect Dis (Lond); 2018; 50(11-12):868-870. PubMed ID: 30296864
    [No Abstract]   [Full Text] [Related]  

  • 11. [Shorter treatment of pulmonary tuberculosis is only acceptable with at least 4 drugs in the initial combination of tuberculostatic agents].
    Veen J
    Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2164-7. PubMed ID: 8984351
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for
    Catanzaro DG; Trollip AP; Seifert M; Georghiou SB; Garfein RS; Rodwell TC; Catanzaro A; Eisenach KD
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28381434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 14. Dried blood spot analysis combined with limited sampling models can advance therapeutic drug monitoring of tuberculosis drugs.
    Alffenaar JW
    J Infect Dis; 2012 Jun; 205(11):1765-6; author reply 1766. PubMed ID: 22459734
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multidrug-resistant tuberculosis].
    Mori T
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):192-4. PubMed ID: 10088371
    [No Abstract]   [Full Text] [Related]  

  • 16. Applicability of the World Health Organization recommended new shorter regimen in a multidrug-resistant tuberculosis high burden country.
    Javaid A; Ahmad N; Khan AH; Shaheen Z
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28049176
    [No Abstract]   [Full Text] [Related]  

  • 17. DOTS in Haiti.
    Ollé-Goig JE
    Int J Tuberc Lung Dis; 2000 Mar; 4(3):282-3. PubMed ID: 10751080
    [No Abstract]   [Full Text] [Related]  

  • 18. Acquired drug resistance during inadequate therapy in a young child with tuberculosis.
    Garcia-Prats AJ; Willemse M; Seifart HI; Jordaan AM; Werely CJ; Donald PR; Schaaf HS
    Pediatr Infect Dis J; 2014 Aug; 33(8):883-5. PubMed ID: 25222312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The analysis of clinical data about the treatment of linezolid against tuberculosis].
    Nie WJ; Chu NH
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):601-3. PubMed ID: 24252739
    [No Abstract]   [Full Text] [Related]  

  • 20. M tuberculosis drug resistance in AIDS.
    Durrheim DN; Levin J; Weyer K
    Lancet; 1997 Jan; 349(9044):61; author reply 61-2. PubMed ID: 8988144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.